Aortic Root and Ascending Aortic Aneurysm Related to One Case. Reimplantation of the Right Coronary Artery by 8 mm Dacron Tube (Cabrol Hemi Mustache) and Review of the Literature
The aortic aneurysm is the 13th leading cause of death in Western countries. The incidence of thoracic aortic aneurysms is estimated at 4.5 cases per 100,000. The diagnosis is often made on a chest x-ray or other imaging tests, such as an echocardiogram done for other heart diseases. Echocardiography is the first test to assess the diameter of the ascending aorta and its progression over time. Most patients are first assessed and followed up with spiral thoracic computed tomography with injection of contrast medium, supplemented by 3-dimensional reconstruction of the aneurysm in order to improve the accuracy of measurements, identification of its proximal part and distal. When dilation of the ascending aorta reaches the critical diameter of 50 mm, there is a risk of aortic dissection or rupture. Supravalvular aneurysms are treated by replacing the ectatic portion with a Dacron® tube in the supracoronary position. Aortic root aneurysms, including coronary ostia, require tube replacement, reimplantation of coronary ostia, as well as surgery on the aortic valve. In this article, we report a case of aneurysm of the aortic root and the ascending aorta treated by aortic valve replacement and the ascending aorta associated with the Cabrol hemi-mustache technique and we review the literature.
Bickerstaff, L.K., Pairolero, P.C., Hollier, L.H., Melton, L.J., Van Peenen, H.J., et al. (1982) Thoracic Aortic Aneurysms: A Population Based Study. Surgery, 92, 1103-1108.
[3]
Coady, M.A., Rizzo, J.A., Goldsttein, L.J. and Elefteriades, J.A. (1999) Natural History, Pathogenesis, and Etiology of Thoracic Aortic Aneurysms and Dissections. Cardiology Clinics, 17, 615-635. https://doi.org/10.1016/S0733-8651(05)70105-3
[4]
Jondeau, G., Barthelet, M., Baumann, C., Bonnet, D., Chevallier, B., Collignon, P., et al. (2006) Recommendations on the Drug Management of Aortic Involvement in Marfan Syndrome. Arch Evil Heart Vaiss, 99, 540-546.
[5]
Nistri, S., Basso, C., Marzari, C., Mormino, P. and Thiene, G. (2005) Frequency of Bicuspi Aortic Valve in Young Male Conscripts by Echocardiogram. American Journal of Cardiology, 96, 718-721. https://doi.org/10.1016/j.amjcard.2005.04.051
[6]
Davies, R.R., Goldstein, L.J., Coady, M.A., Tittle, S.L., Rizzo, J.A., Kopf, G.S., et al. (2002) Yearly Rupture or Dissection Rates for Thoracic Aortic Aneurysms: Simple Prediction Based on Size. The Annals of Thoracic Surgery, 73, 17-27. https://doi.org/10.1016/S0003-4975(01)03236-2
[7]
Touat, Z., Lepage, L., Ollivier, V., Nataf, P., Hvass, U. and Labreuche, J. (2008) Dilatation-Dependent in Human Thoracic Ascending Aortic Aneurysm. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 940-946. https://doi.org/10.1161/ATVBAHA.107.158576
[8]
Shores, J., Berger, K.R., Murphy, E.A. and Pyeritz, R.E. (1994) Progression of Aortic Dilatation and the Benefit of Long-Term Beta-Adrenergic Blockade in Marfan’s Syndrome. The New England Journal of Medicine, 330, 1335-1341. https://doi.org/10.1056/NEJM199405123301902
[9]
Brooke, B.S., Habashi, J.P., Judge, D.P., Patel, N., Loeys, B. and Dietz III, H.C. (2008) Angiotensin II Blockade and Aortic-Root Dilatation in Marfan’s Syndrome. The New England Journal of Medicine, 26, 2787-2795. https://doi.org/10.1056/NEJMoa0706585
[10]
Lung, B., Gohlke-Barwolf, C., Tornos, P., Tribouilloy, C., Hall, R., Butchart, E., et al. (2002) For the Working Group on Valvular Heart Disease. Recommendations on the Management of the Asymptomatic Patient with Valvular Heart Disease. European Heart Journal, 23, 1252-1266. https://doi.org/10.1053/euhj.2002.3320
[11]
Vahanian, A., Baumgartner, H., Bax, J., Butchart, E., Dion, R., Filippatos, G., et al. (2007) Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the Management of Valvular Heart Disease: The Task Force on the Management of Valvular Heart Disease of the Aeropean Society of Cardiology. European Heart Journal, 28, 230-268.
[12]
Bonow, R.O., Carabello, B.A., Kanu, C., de Leon, A.C.J.R., Faxon, D.P., Freed, M.D., et al. (2006) American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): Developed in Collaboration with the Society of Cardiolovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation, 114, e84-e231. https://doi.org/10.1161/CIRCULATIONAHA.106.177303
[13]
Al-Attar, N. And Patrick, N. (2019) Anévrisme de l’aorte ascendante. Cardiologie. Presse med.